NYSE Euronext Company Profile
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trade equities, futures, options, fixed-income and exchange-traded products. With approximately 8,000 listed issues (excluding European Structured Products), NYSE Euronext's equities markets â the New York Stock Exchange, NYSE Euronext, NYSE Amex, NYSE Alternext and NYSE Arca â represent one-third of the world's equities trading, the most liquidity of any global exchange group. NYSE Euronext also operates NYSE Liffe, one of the leading European derivatives businesses and the world's second-largest derivatives business by value of trading. The company offers comprehensive commercial technology, connectivity and market data products and services through NYSE Technologies. NYSE Euronext is in the S&P 500 index, and is the only exchange operator in the Fortune 500. For more information, please visit: http://www.nyx.com.
News Articles
Nanobiotix gains on NYSE Euronext debut
Nanobiotix S.A. (Euronext:NANO) gained EUR 0.20 to EUR 6.20 in its first day of trading Monday on NYSE Euronext Paris. Last week, the company raised EUR 14.2 million ($18.5 million) through the sale o...
Galapagos NV: NYSE Liffe lists Equity Options on Galapagos
Brussels and Mechelen, Belgium, 30 April 2013 - Today NYSE Liffe, the Europe-based derivatives business of NYSE Euronext (NYX), added options on the shares of Galapagos (Euronext: GLPG), a clinica...
[Erytech Pharma] files for IPO on the NYSE Euronext
[Erytech Pharma SA] (developing therapeutics mainly for cancer; also has immune and blood projects in the works) has filed for its initial public offering on the NYSE Euronext Paris Regulated Market....
CHICAGO, Oct. 2, 2012 /PRNewswire/ -- Zacks Equity Research highlights Align Technology, Inc. (Nasdaq:ALGN) as the Bull of the Day and NYSE Euronext, Inc. (NYSE:NYX) as the Bear of the Day. In add...
Xconomy Not Going Public, But We Had a Great Time at NYSE Euronext—Thanks to Our New York Supporters
Xconomy held a great party last Thursday on the floor of the New York Stock Exchange. The only caveats from our fantastic host NYSE Euronext was that if I rang the bell, the symbol XCON would never tr...
Erytech sets out its stall ahead of NYSE Euronext listing
French biopharma company Erytech Pharma, a company that designs innovative treatments for acute leukemia and other oncology indications with unmet medical needs, says that the French market regulator,...
Theradiag slips in Euronext trading debut
Diagnostics company Theradiag (Euronext:ALTER) was down EUR 0.14 to EUR 5.66 in its first day of trading Tuesday on NYSE Euronext Paris. Last week, the company raised EUR 8.2 million ($10.6 million) t...
AMSTERDAM, November 6, 2012 /PRNewswire/ -- Amsterdam Molecular Therapeutics (AMT) Holding NV in liquidation (in liquidatie) (Euronext: AMT) announces that NYSE Euronext has determined and announc...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
NYSE Euronext (NYX) is a leading global operator of financial markets and provider of innovative trading technologies. The company's exchanges in Europe and the United States trad...
Euronext N.V., a holding company incorporated under Dutch law that operates through local subsidiaries, was formed on 22 September 2000 when the exchanges of Amsterdam, Brussels and Paris merged. The...
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) a...
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Paris (EURONEXT: SAN) a...
Sanofi-aventis, a leading global pharmaceutical company, discovers, develops and distributes therapeutic solutions to improve the lives of everyone. Sanofi-aventis is listed in Pa...
More Information about "NYSE Euronext" on BioPortfolio
We have published hundreds of NYSE Euronext news stories on BioPortfolio along with dozens of NYSE Euronext Clinical Trials and PubMed Articles about NYSE Euronext for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of NYSE Euronext Companies in our database. You can also find out about relevant NYSE Euronext Drugs and Medications on this site too.
